Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Camille Aubron-Olivier"'
Autor:
Roland Tubiana, Brigitte Autran, Geneviève Chêne, Marianne Savès, Maryem Nciri, Stéphane Lasry, Guislaine Carcelain, Marc Jouan, Brigitte Senechal, Christina Tural, Nathalie Cassoux, Anne-Marie Fillet, Christine Katlama, Camille Aubron-Olivier
Publikováno v:
AIDS. 15:23-31
Objective: To study the safety of discontinuing cytomegalovirus (CMV) maintenance therapy among patients with cured CMV retinitis receiving highly active antiretroviral therapy (HAART). Methods: Patients with a history of CMV retinitis who were recei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf333ae5a4dd515ce19882b8af10031d
https://doi.org/10.1097/00002030-200101050-00006
https://doi.org/10.1097/00002030-200101050-00006
Publikováno v:
AIDS. 16:131-133
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e38873c3bdb2678969551a467659682
https://doi.org/10.1097/00002030-200201040-00020
https://doi.org/10.1097/00002030-200201040-00020
Autor:
Lionel Karlin, Jean-Philippe Metges, Domitille Fernet, Alain Toledano, Olivier Fitoussi, Camille Aubron-Olivier, Gilles Boschetti, Nataliya Khobta
Publikováno v:
Blood. 126:3342-3342
Background. OncoBOS is a prospective, non-interventional study conducted in France to describe modalities of treatment with Binocrit® in routine clinical practice setting, for the correction of hemoglobin (Hb) in patients with CIA receiving chemothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58aada642050e675208695ac9d715b51
https://doi.org/10.1182/blood.v126.23.3342.3342
https://doi.org/10.1182/blood.v126.23.3342.3342
Autor:
Corinne Haioun, Kun-Lun Liu, Philippe Solal-Celigny, Henri Roché, Jean-Christophe Eymard, Omar Benbrahim, Camille Aubron-Olivier, Inna Voronina, Gandhi Damaj, Alain Toledano, Isabelle Gasnereau
Publikováno v:
Journal of Clinical Oncology. 33:e20655-e20655
e20655 Background: Guidelines recommend granulocyte-colony stimulating factor use to reduce the risk of neutropenic complications in patients receiving CT and to enable delivery of full-dose CT. ZO...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40ec78d50b48384e055e483f11b18175
https://doi.org/10.1200/jco.2015.33.15_suppl.e20655
https://doi.org/10.1200/jco.2015.33.15_suppl.e20655
Autor:
Jean Philippe Metges, Gilles Boschetti, Sophie Nahon, Daniela Petran, Jean-Pierre Crumbach, Jérôme Desramé, Otilia Stamerra, Camille Aubron-Olivier, Vincent Boulanger, Domitille Fernet
Publikováno v:
Journal of Clinical Oncology. 33:479-479
479 Background: OncoBOS is a prospective, non-interventional study describing Binocrit use in routine practice in France in patients receiving chemotherapy treatment (CT) for solid tumors, lymphoma or myeloma. This interim sub-analysis focuses on pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26802a08a0b4476c37fb4f4424727fd2
https://doi.org/10.1200/jco.2015.33.3_suppl.479
https://doi.org/10.1200/jco.2015.33.3_suppl.479
Autor:
Jean Philippe Metges, Jean-Pierre Crumbach, Daniela Petran, Vincent Boulanger, Otilia Stamerra, Jérôme Desramé, Sophie Nahon, Camille Aubron-Olivier, Domitille Fernet, Gilles Boschetti
Publikováno v:
Journal of Clinical Oncology. 33:742-742
742 Background: OncoBOS is a prospective, non-interventional study describing Binocrit use in routine practice in France in patients receiving chemotherapy treatment (CT) for solid tumors, lymphoma, or myeloma. This interim sub-analysis focuses on pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab29300eb2524941e369d75e47e0c9c3
https://doi.org/10.1200/jco.2015.33.3_suppl.742
https://doi.org/10.1200/jco.2015.33.3_suppl.742
Autor:
Camille Aubron-Olivier, Jade Ghosn, Hassan Izzedine, Christine Katlama, Nadine Ktorza, Aldo Trylesinski, Gilbert Deray, Gilles Peytavin, Marc Wirden, Vincent Calvez, Michael W. Miller, Stéphanie Dominguez
Publikováno v:
Journal of medical virology. 79(2)
Drug resistance is an increasing problem in the treatment of HIV infection. Tenofovir has been shown to inhibit HIV replication even with thymidine-associated resistance mutations (TAMs) if they are limited to two or less. Double-dose of tenofovir di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3027dfaf46e95be7d56732b2054f7cd
https://pubmed.ncbi.nlm.nih.gov/17177308
https://pubmed.ncbi.nlm.nih.gov/17177308
Autor:
Raymond Bousquet, Philippe Katz, Camille Aubron-Olivier, Dominique Costagliola, Marc-Antoine Valantin, Michelle Pauchard, Christine Katlama, Elisabeth Laglenne, Jade Ghosn, Hélène Schoen
Publikováno v:
AIDS (London, England). 17(17)
Background In the absence of currently available therapy to manage facial lipoatrophy, strategies used to compensate for facial fat loss warrant clinical evaluation. Methods The goal of this open-label, single-arm, pilot study was to evaluate the eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::192692487fde8a1b34f96af3814fa736
https://pubmed.ncbi.nlm.nih.gov/14600527
https://pubmed.ncbi.nlm.nih.gov/14600527
Autor:
Olivier Fitoussi, Lionel Karlin, Mario Ojeda-Urib, Laurent Voillat, Irina Voronina, Charles Dauriac, Camille Aubron-Olivier, Domitille Fernet
Publikováno v:
Blood. 124:4001-4001
Background: OncoBOS is a national, prospective, non-interventional, longitudinal, observational study describing biosimilar epoetin alfa (Binocrit®) use in routine practice in France in patients receiving chemotherapy treatment (CT) for solid tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::074ee41467393e1b8283aae8b41a862e
https://doi.org/10.1182/blood.v124.21.4001.4001
https://doi.org/10.1182/blood.v124.21.4001.4001
Autor:
Yves Benhamou, Dominique Thabut, Vincent Di Martino, Thierry Poynard, Camille Aubron-Olivier, B Bernard, Vincent Thibault
Publikováno v:
AIDS. 15:2463-2464
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17c1d5001f2c2db18cab02c3e3869b58
https://doi.org/10.1097/00002030-200112070-00020
https://doi.org/10.1097/00002030-200112070-00020